SCHEMBL1725486

SCHEMBL1725486

NC(=O)c1ccc(C(=O)O)c(C(N)=O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.52
CDC25A P30304 1/20 0.52
CDC25B P30305 1/20 0.52
TDP1 Q9NUW8 3/20 0.50
POLB P06746 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 2/20 0.50
TSHR P16473 2/20 0.46
PARP1 P09874 6/20 0.44
MAPT P10636 3/20 0.44
CYP2C19 P33261 2/20 0.44
CYP3A4 P08684 2/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
PARP15 Q460N3 1/20 0.44
PARP10 Q53GL7 1/20 0.44
LCK P06239 1/20 0.44
ALDH1A1 P00352 2/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28221470 0.93 HSD17B10 (0.59) HSD17B10CDC25ACDC25BTDP1POLB
SCHEMBL6597584 0.91 HSD17B10 (0.52) HSD17B10CDC25ACDC25BTDP1POLB
SCHEMBL829773 0.91 KDM4E (0.60) HSD17B10CDC25ACDC25BTDP1POLB
SCHEMBL10046617 0.89 POLB (0.63) HSD17B10CDC25ACDC25BTDP1POLB
SCHEMBL11555300 0.89 LCK (0.48) HSD17B10TDP1POLBL3MBTL1KDM4E
SCHEMBL30342277 0.89 LCK (0.48) HSD17B10TDP1POLBL3MBTL1KDM4E
SCHEMBL31161441 0.83 MYC (0.48) HSD17B10CDC25ACDC25BTDP1POLB
SCHEMBL27748287 0.83 KDM4E (0.55) HSD17B10CDC25ACDC25BTDP1POLB
SCHEMBL6946130 0.83 KDM4E (0.55) HSD17B10CDC25ACDC25BTDP1POLB
SCHEMBL2422954 0.81 ALDH1A1 (0.49) HSD17B10TDP1POLBL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101568351-B Controlled release composition and process 3M INNOVATIVE PROPERTIES CO 2012-05-30 CN disclosed
EP-2406250-A1 INHIBITORS OF AKT ACTIVITY Merck Sharp & Dohme Corp. (US) 2012-01-18 EP disclosed
EP-0722936-B1 FUSED PYRIDAZINE COMPOUND EISAI CO LTD (JP) 2004-05-19 EP disclosed
US-6218392-B1 FOR THERAPY AND PROPHYLAXIS OF ISCHEMIC HEART DISEASES SUCH AS ANGINA PECTORIS, MYOCARDIAL INFARCT AND CHRONIC AND ACUTE CARDIAC FAILURE, PULMONARY HYPERTENSION, ARTERIOSCLEROSIS AND BRONCHIAL ASTHMA EISAI CO., LTD. (JP) 2001-04-17 US disclosed
US-5849741-A Fused pyridazine compounds EISAI CO., LTD. (JP) 1998-12-15 US disclosed
EP-0722936-A1 FUSED PYRIDAZINE COMPOUND Eisai Co., Ltd. (JP) 1996-07-24 EP disclosed